Copyright © 2000 by the European Society of Cardiology.
Letter to the Editor
Natriuretic peptides in clinical practice
Research Institute for Internal Medicine, University of Oslo, The National Hospital, Oslo, Norway
References
- Moe GW, Rouleau JL, Proulx G, Arnold M, Sestier F. Increased mortality with flosequinan in patients with failure is accompanied by increased plasma norepinephrine (Abstr). Circulation. 1994;90:
- Klinge R, Polis A, Dickstein K, Hall C. Effects of angiotensin II receptor blockage on N-terminal proatrial natriuretic factor plasma levels in chronic heart failure. J Cardiac Failure. 1997;3:7581[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||